Endocrinology

The Biology and Diagnosis of AIS

At a Glance

Androgen Insensitivity Syndrome (AIS) occurs when a person has a 46,XY chromosome pattern but their cells cannot respond to male hormones due to an AR gene mutation. Doctors diagnose AIS using hormone panels, karyotyping, ultrasounds, and AR genetic sequencing to identify the exact mutation.

While the physical signs of Androgen Insensitivity Syndrome (AIS) are what often lead to a diagnosis, the “engine” of the condition lies deep within the cells. Understanding the biology of AIS helps clarify why the body develops the way it does and how doctors confirm the diagnosis with such precision.

The Genetic Blueprint: 46,XY

Every person typically has 46 chromosomes in their cells. Most people who develop as females have two X chromosomes (46,XX), while most who develop as males have one X and one Y chromosome (46,XY). In AIS, the genetic blueprint is 46,XY ^[1]^[2].

The Y chromosome contains a gene called SRY, which instructs the body to develop testes instead of ovaries. In people with AIS, these testes develop normally and produce male hormones, including testosterone and Anti-Müllerian Hormone (AMH) ^[3]^[4].

The Role of the Androgen Receptor

The reason the body does not develop male physical characteristics, despite having XY chromosomes and producing testosterone, is a change in the AR gene ^[5]^[6]. This gene provides instructions for making the androgen receptor, a protein that acts like a cellular “ear.”

How it should work: Normally, testosterone and its more powerful form, Dihydrotestosterone (DHT), enter a cell and “talk” to the androgen receptor. The receptor “hears” the message and tells the cell’s DNA to start building male-typical physical features ^[7]^[8].
The AIS “Communication Gap”: In AIS, a mutation in the AR gene makes the receptor partially or completely “deaf” to these hormones ^[9]^[10]. Even though the hormones are present in high amounts, the body cannot respond to them. This is often called end-organ resistance to androgens ^[9].

How Doctors Confirm the Diagnosis

Because several conditions can look similar, doctors use a specific set of tests to distinguish AIS from other Differences of Sex Development (DSD).

1. Hormone Analysis

In AIS, the hormone profile is very distinctive:

Testosterone: Levels are usually normal or high for a male ^[3]^[11].
AMH (Anti-Müllerian Hormone): Levels are typically high ^[3]^[4]. AMH is produced by the testes and prevents the development of a uterus and fallopian tubes.
T/DHT Ratio: Doctors look at the ratio of testosterone to DHT. In AIS, this ratio is low or normal, which helps rule out 5-alpha reductase deficiency (where the ratio is very high) ^[12]^[13].

2. Karyotyping and Imaging

A karyotype test is performed to confirm the 46,XY chromosome pattern ^[14]. Additionally, an ultrasound or MRI is used to confirm the absence of a uterus and the presence of internal testes, which are often located in the abdomen or groin ^[2]^[15].

3. Genetic Sequencing

The final, definitive step is AR gene sequencing. This test looks for a specific mutation in the androgen receptor gene. While most people with AIS will have an identifiable mutation, a small percentage may have “mutation-negative” AIS, where the resistance exists but the specific genetic cause isn’t yet visible through current testing ^[16]^[17].

Diagnosis Checklist

If you or your child are in the process of being diagnosed, a comprehensive workup should include:

[ ] Karyotype: To confirm the 46,XY chromosome pattern ^[2].
[ ] Hormone Panel: Including Testosterone, DHT, AMH, and LH ^[3].
[ ] Imaging: Ultrasound or MRI to check for internal structures ^[15].
[ ] Genetic Testing: Sequencing of the AR gene ^[11]. Note: This test can take several weeks to return, which can be an anxious waiting period.
[ ] Physical Exam: Assessment of external features and checking for hernias ^[11].

Distinguishing AIS from “Look-Alikes”

Condition	Testosterone Levels	AMH Levels	Internal Structures	Pubertal Development
AIS	Normal/High	High	Testes present; No uterus ^[3]	Female (in CAIS) or variable (in PAIS) due to aromatization of testosterone to estrogen.
5-Alpha Reductase Deficiency	Normal/High	Normal	Testes present; No uterus ^[13]	Significant virilization/masculinization.
Gonadal Dysgenesis	Low	Low	Uterus often present ^[3]	Minimal spontaneous pubertal development.

Common questions in this guide

What causes Androgen Insensitivity Syndrome?

AIS is caused by a change or mutation in the AR gene. This gene provides instructions for making the androgen receptor, and when it is mutated, it prevents the body's cells from 'hearing' or responding to male hormones like testosterone.

What tests are used to diagnose AIS?

Doctors diagnose AIS using a combination of blood tests to check hormone levels, karyotyping to confirm the 46,XY chromosome pattern, and imaging like an ultrasound or MRI to locate internal structures. A definitive diagnosis is usually confirmed with AR gene sequencing.

Why are testosterone levels normal or high in someone with AIS?

People with AIS have internal testes that produce testosterone just as they normally would. However, because the body's androgen receptors cannot respond to the hormone, the testosterone remains in the bloodstream at normal or high levels.

How is AIS different from 5-alpha reductase deficiency?

While both are differences of sex development, they have distinct hormone profiles. In AIS, the ratio of testosterone to DHT is low or normal, whereas in 5-alpha reductase deficiency, this ratio is very high. AIS also typically presents with high AMH levels.

What does it mean if my AR genetic test is negative but I have AIS symptoms?

A small percentage of people have 'mutation-negative' AIS. This means that while their body clearly shows resistance to androgens, the specific genetic cause is not yet visible using current genetic sequencing technology.

Curated prompts to bring to your next appointment.

1.Based on the genetic sequencing, what is the specific mutation in my or my child's AR gene?
2.How do the testosterone and AMH levels help confirm this is AIS rather than 5-alpha reductase deficiency?
3.If the genetic test is negative, what other tests would you perform to confirm the diagnosis?
4.Does the specific mutation identified provide any insight into how the body might respond to hormone replacement therapy in the future?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (17)

1
Incidence, Prevalence, Diagnostic Delay, and Clinical Presentation of Female 46,XY Disorders of Sex Development.
Berglund A, Johannsen TH, Stochholm K, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(12)):4532-4540 doi:10.1210/jc.2016-2248.
PMID: 27603905
2
Primary Amenorrhea Due to Anatomical Abnormalities of the Reproductive Tract: Molecular Insight.
Kapczuk K, Kędzia W
International journal of molecular sciences 2021; (22(21)) doi:10.3390/ijms222111495.
PMID: 34768925
3
Anti-Müllerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis.
Edelsztein NY, Grinspon RP, Schteingart HF, Rey RA
International journal of pediatric endocrinology 2016; (2016()):20 doi:10.1186/s13633-016-0038-2.
PMID: 27799946
4
Complete androgen insensitivity syndrome and anti-Müllerian hormone levels before and after laparoscopic gonadectomy.
Kusumi M, Mitsunami M, Onoue H, et al.
Gynecology and minimally invasive therapy 2017; (6(3)):126-128 doi:10.1016/j.gmit.2016.11.001.
PMID: 30254896
5
Complete androgen insensitivity syndrome caused by a novel mutation in the androgen receptor gene and its mechanism.
Zhou D, Xu H, Shen X, et al.
Clinica chimica acta; international journal of clinical chemistry 2022; (531()):94-99 doi:10.1016/j.cca.2022.03.021.
PMID: 35351434
6
Preimplantation Genetic Diagnosis of Androgen Resistance Syndrome Caused by Mutation on the AR Gene in Vietnam.
Tung NT, Sang TT, Khoa TV, et al.
The application of clinical genetics 2024; (17()):47-56 doi:10.2147/TACG.S457634.
PMID: 38737445
7
Complete Androgen Insensitivity Syndrome due to Mutations in the DNA-Binding Domain of the Human Androgen Receptor Gene.
Chauhan P, Rani A, Singh SK, Rai AK
Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2018; (12(6)):269-274 doi:10.1159/000492261.
PMID: 30165367
8
Structural mechanism underlying variations in DNA binding by the androgen receptor.
Lee XY, Van Eynde W, Helsen C, et al.
The Journal of steroid biochemistry and molecular biology 2024; (241()):106499 doi:10.1016/j.jsbmb.2024.106499.
PMID: 38604378
9
Androgen insensitivity syndrome.
Mongan NP, Tadokoro-Cuccaro R, Bunch T, Hughes IA
Best practice & research. Clinical endocrinology & metabolism 2015; (29(4)):569-80.
PMID: 26303084
10
Somatic mosaicism of androgen receptor gene in an androgen insensitivity syndrome patient conceived through assisted reproduction technique.
Wang H, Zhu H, Wang N, et al.
Molecular genetics & genomic medicine 2019; (7(10)):e00906 doi:10.1002/mgg3.906.
PMID: 31429517
11
Complete androgen insensitivity syndrome in a 15-year-old female with primary amenorrhea and undescended testes: a rare case report.
Zerin F, Bhadra TK, Sadia R, Shahriar Z
Radiology case reports 2026; (21(1)):329-332 doi:10.1016/j.radcr.2025.09.075.
PMID: 41209089
12
Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD
Akcan N, Uyguner O, Baş F, et al.
Journal of clinical research in pediatric endocrinology 2022; (14(2)):153-171 doi:10.4274/jcrpe.galenos.2022.2021-9-19.
PMID: 35135181
13
Diagnostic accuracy of human chorionic gonadotropins (HCG) stimulation test in XY-disorders of sex development (XY-DSD) presented in Armed Forces Institute of Pathology.
Sheikh WH, Asif N, Haroon ZH, et al.
JPMA. The Journal of the Pakistan Medical Association 2019; (69(8)):1090-1093.
PMID: 31431758
14
[Complete androgen insensitivity syndrome].
Gajić TM, Vujović S, Ivović M, et al.
Srpski arhiv za celokupno lekarstvo 2015; (143(3-4)):214-8.
PMID: 26012135
15
An Early Case of Complete Androgen Insensitivity Syndrome.
Matalka L, Dean SJ, Beauchamp G, Sunil B
Journal of investigative medicine high impact case reports 2023; (11()):23247096231157918 doi:10.1177/23247096231157918.
PMID: 36852701
16
Phenotypic and molecular characteristics of androgen insensitivity syndrome patients.
Yuan SM, Zhang YN, Du J, et al.
Asian journal of andrology 2018; (20(5)):473-478 doi:10.4103/aja.aja_17_18.
PMID: 29785970
17
Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity.
Hornig NC, Ukat M, Schweikert HU, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(11)):4468-4477 doi:10.1210/jc.2016-1990.
PMID: 27583472

This page explains the biology and diagnostic testing for Androgen Insensitivity Syndrome for educational purposes only. Always consult your endocrinologist or genetic counselor to interpret your specific lab and genetic test results.

Get notified when new evidence is published on Androgen insensitivity syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents